Head-to-head
Noom Med vs bmiMD
Compared on semaglutide across the eight dimensions this database records. They differ on 5 of those eight. bmiMD is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Noom Med is $199 a month all-in for semaglutide; bmiMD is $129. Over twelve months that is $2,388 against $1,188. Value Scores are 73.1 and 95.5 out of 100.
Semaglutide
Plan pages: Noom Med plans · bmiMD plans
At 2.4 mg/week, Noom Med is $199 a month all-in and bmiMD is $129 — $70 apart, or $840 across a year. Over twelve months the totals are $2,388 (billed monthly) and $1,188 (prepaid term).
Noom Med charges a flat $199 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
bmiMD charges a flat $129 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | Noom Med | Rank | bmiMD | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $199 | 17/32 | $129 | 2/32 | bmiMD by $70 |
| 0.5 mg | $199 | 12/21 | $129 | 1/21 | bmiMD by $70 |
| 1 mg | $199 | 12/21 | $129 | 1/21 | bmiMD by $70 |
| 1.7 mg | $199 | 12/21 | $129 | 1/21 | bmiMD by $70 |
| 2.4 mg | $199 | 14/29 | $129 | 1/29 | bmiMD by $70 |
bmiMD is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, Noom Med sits 10 of 29 on all-in monthly cost and bmiMD sits 1. There are 8 other programs priced between them. The field median is $249 and the floor is $129, so both sit below the median. Noom Med is $70 above the cheapest semaglutide program on record. bmiMD is the cheapest semaglutide program on record at this basis.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — Noom Med undercuts it by $150, bmiMD by $220. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Noom Med | bmiMD | Cheaper |
|---|---|---|---|
| Month to month | $199 | $129 | bmiMD by $70 |
| 3-month term | — | $119 | only bmiMD publishes this term |
| 6-month term | — | $109 | only bmiMD publishes this term |
| 12-month term | — | $99 | only bmiMD publishes this term |
| Settled dose | Noom Med | bmiMD | Difference |
|---|---|---|---|
| 0.25 mg | $2,388 | $1,548 | $840 apart |
| 0.5 mg | $2,388 | $1,548 | $840 apart |
| 1 mg | $2,388 | $1,548 | $840 apart |
| 1.7 mg | $2,388 | $1,548 | $840 apart |
| 2.4 mg | $2,388 | $1,548 | $840 apart |
Noom Med publishes no rate for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $2,388 on Noom Med and $1,548 on bmiMD. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.
Value Scores are 73.1 for Noom Med and 95.5 for bmiMD, against a semaglutide category floor of $129. bmiMD leads by 22.4 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Noom Med | 45.4 | 12.8 | 10 | 5 | 73.1 |
| bmiMD | 70.0 | 10.5 | 10 | 5 | 95.5 |
Where the two programs differ
All-in monthly
bmiMD is cheaper month to month — $129 against $199, a gap of $70 every month, or $840 across a year if both rates hold.
Cancellation terms
Cancellation differs: Noom Med states Per plan terms, while bmiMD states Per provider terms; confirm cancellation policy at enrollment. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Noom Med asks for Program-based; bmiMD asks for Monthly, 3-month, 6-month, or 12-month plans; price varies by term, not by dose. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Evidence status
The two prices are not equally well evidenced. Noom Med's figure is provider-stated and bmiMD's is reported. Noom Med rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $2,388 for Noom Med and $1,188 for bmiMD. bmiMD is lower by $1,200 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Dose policy
Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Noom Med Official site
Noom bundles its behavior program with medication access; compounded semaglutide lists at $199/month all-in.
It names its compounding pharmacy — Partner pharmacies, recorded as Partner network — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Program-based; cancellation is Per plan terms; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — noom.com program page capture 2026-08-08
Watch: Noom's program bundling changes frequently; confirm what the quoted figure includes.
bmiMD Official site
bmiMD is a compounded GLP-1 telehealth platform notable for flat per-dose pricing — the rate stays the same whether you're at 2.5 mg or 15 mg — and one of the widest plan-tier menus in the market. Its $99/mo semaglutide and $139/mo tirzepatide on the twelve-month plan are the lowest annualized figures in the dataset for both molecules.
It does not publicly name its compounding pharmacy; the record shows Named 503A pharmacy partner (specific pharmacy not publicly identified on pricing page), so who actually makes the medication cannot be independently verified; commitment terms are Monthly, 3-month, 6-month, or 12-month plans; price varies by term, not by dose; cancellation is Per provider terms; confirm cancellation policy at enrollment; availability is stated as Availability at enrollment; confirm your state at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com cheapest-compounded-tirzepatide-online, capture verified 2026-07-14
Watch: bmiMD's 12-month semaglutide plan at $99/mo is the lowest annualized sema figure in our dataset, beating NexLife's $119/mo and Oak's $133 m2m. Month-to-month sema at $129 also beats Oak's $133, making bmiMD the new m2m sema leader. Tirzepatide 12-month at $139 ties NexLife. Figures are reported status from RangeYourself's July 2026 first-party captures; our independent checkout is pending.
Which molecules each one carries
Noom Med carries semaglutide at $199 a month; does not offer tirzepatide.
bmiMD carries tirzepatide at $179 a month and semaglutide at $129 a month.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Noom Med does not publish
- no published twelve-month semaglutide rate
- no state-by-state availability list — it says Most US states
- no specific cancellation or refund terms
bmiMD does not publish
- no named compounding pharmacy
- no state-by-state availability list — it says Availability at enrollment; confirm your state at intake
- no specific cancellation or refund terms
Ask Noom Med and bmiMD for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. bmiMD carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. bmiMD publishes a twelve-month rate of $99 a month against $129 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, bmiMD Official site wins this matchup. And if you would rather trust a better-evidenced number, noom med's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Noom Med's semaglutide price is provider-stated as of 2026-08-08; bmiMD's is reported as of 2026-07-14.
Questions
Is Noom Med or bmiMD cheaper for semaglutide?
bmiMD is cheaper on all-in monthly cost at 2.4 mg/week: $129 against $199, a difference of $70 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Noom Med versus bmiMD?
Noom Med works out to $2,388 across twelve months and bmiMD to $1,188, on the plan terms each publishes.
Does Noom Med or bmiMD raise the price as the dose goes up?
Noom Med: no, it charges one flat rate at every dose. bmiMD: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Noom Med and bmiMD differ?
5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Noom Med and bmiMD names its pharmacy?
Noom Med does — Partner pharmacies. bmiMD does not, recording only Named 503A pharmacy partner (specific pharmacy not publicly identified on pricing page), so who makes its medication cannot be independently verified.
How well evidenced are the Noom Med and bmiMD prices?
Noom Med's semaglutide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-08. bmiMD's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Noom Med official site · bmiMD official site. Compounded tirzepatide and semaglutide are not FDA-approved products.